.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Accenture
Baxter
Queensland Health
Harvard Business School
McKinsey
QuintilesIMS
Fish and Richardson
US Department of Justice
Cantor Fitzgerald

Generated: December 18, 2017

DrugPatentWatch Database Preview

Patents Expiring in May 2027

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Actelion Pharms LtdOPSUMITmacitentanTABLET;ORAL204410-001Oct 18, 2013RXYesYes► Subscribe► SubscribeYMETHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION BY ADMINISTERING A PHARMACEUTICAL COMPOSITION COMPRISING MACITENTAN AND A POLYSORBATE, WHEREIN THE POLYSORBATE REPRESENTS 0.1 TO 3% OF THE WEIGHT OF SAID PHARMACEUTICAL COMPOSITION
Novartis Pharms CorpENTRESTOsacubitril; valsartanTABLET;ORAL207620-001Jul 7, 2015RXYesNo► Subscribe► SubscribeYY
Novartis Pharms CorpENTRESTOsacubitril; valsartanTABLET;ORAL207620-003Jul 7, 2015RXYesYes► Subscribe► SubscribeYY
Novartis Pharms CorpENTRESTOsacubitril; valsartanTABLET;ORAL207620-002Jul 7, 2015RXYesNo► Subscribe► SubscribeYY
AcordaAMPYRAdalfampridineTABLET, EXTENDED RELEASE;ORAL022250-001Jan 22, 2010ABRXYesYes► Subscribe► SubscribeIMPROVEMENT OF WALKING IN PATIENTS WITH MULTIPLE SCLEROSIS (MS)
Anacor Pharms IncKERYDINtavaboroleSOLUTION;TOPICAL204427-001Jul 7, 2014RXYesYes► Subscribe► Subscribe
Kaleo IncEVZIOnaloxone hydrochlorideSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS209862-001Oct 19, 2016RXYesYes► Subscribe► SubscribeY
Kaleo IncEVZIOnaloxone hydrochlorideSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS205787-001Apr 3, 2014DISCNYesNo► Subscribe► SubscribeY
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeY
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Chinese Patent Office
Moodys
Julphar
Harvard Business School
QuintilesIMS
Dow
UBS
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot